Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 10, Issue 9

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Cover image for Expert Opinion on Investigational Drugs, Volume 10, Issue 9, 2001

Expert Opinion on Investigational Drugs, Volume 10, Issue 9 (2001)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 10, Issue 9 (2001)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Volume 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Miscellaneous

Leptin: brains and bones

James F Whitfield

Pages: 1617-1622

Published online: 24 Feb 2005

AbstractforLeptin: brains and bones | References | PDF (103.1 KB)

72 Views
20 CrossRef citations
0Altmetric

Advances in the treatment of precocious puberty

Erica A Eugster & Ora H Pescovitz

Pages: 1623-1630

Published online: 24 Feb 2005

First Page PreviewforAdvances in the treatment of precocious puberty | References | PDF (122.7 KB)

51 Views
6 CrossRef citations
0Altmetric

Advances in the treatment of polycystic ovary syndrome

Pages: 1631-1640

Published online: 24 Feb 2005

AbstractforAdvances in the treatment of polycystic ovary syndrome | References | PDF (167 KB)

39 Views
4 CrossRef citations
0Altmetric

Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus

Birgit Nyholm, Birgitte Brock, Lotte Ørskov & Ole Schmitz

Pages: 1641-1652

Published online: 24 Feb 2005

AbstractforAmylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus | References | PDF (205 KB)

134 Views
12 CrossRef citations
0Altmetric

Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

Junzo Kamei, Hirokazu Mizoguchi, Minoru Narita & Leon F Tseng

Pages: 1653-1664

Published online: 24 Feb 2005

AbstractforTherapeutic potential of PKC inhibitors in painful diabetic neuropathy | References | PDF (203.9 KB)

70 Views
30 CrossRef citations
0Altmetric

Therapeutic potential of anti-oxidants and diabetic retinopathy

Renu A Kowluru & Alexander Kennedy

Pages: 1665-1676

Published online: 24 Feb 2005

AbstractforTherapeutic potential of anti-oxidants and diabetic retinopathy | References | PDF (240 KB)

132 Views
61 CrossRef citations
0Altmetric

Therapeutic potential of bone morphogenetic proteins

Kodi Azari, Bruce A Doll, Charles Sfeir, Ying Mu & Jeffrey O Hollinger

Pages: 1677-1686

Published online: 24 Feb 2005

First Page PreviewforTherapeutic potential of bone morphogenetic proteins | References | PDF (176.1 KB)

75 Views
13 CrossRef citations
0Altmetric

Therapeutic potential of angiotensin II receptor antagonists

Michel White, Normand Racine, Anique Ducharme & Jacques de Champlain

Pages: 1687-1701

Published online: 24 Feb 2005

AbstractforTherapeutic potential of angiotensin II receptor antagonists | References | PDF (226.9 KB)

58 Views
11 CrossRef citations
0Altmetric

Development of distamycin-related DNA binding anticancer drugs

Sergio Marchini, Massimo Broggini, Cristiana Sessa & Maurizio D’Incalci

Pages: 1703-1714

Published online: 24 Feb 2005

AbstractforDevelopment of distamycin-related DNA binding anticancer drugs | References | PDF (280.2 KB)

82 Views
30 CrossRef citations
0Altmetric

Recent advances in the treatment of epithelial ovarian cancer

Mark Harries & Stanley B Kaye

Pages: 1715-1724

Published online: 24 Feb 2005

AbstractforRecent advances in the treatment of epithelial ovarian cancer | References | PDF (159.5 KB)

109 Views
37 CrossRef citations
0Altmetric

The place of pegvisomant in the management of acromegaly

Craig Parkinson & Peter J Trainer

Pages: 1725-1735

Published online: 24 Feb 2005

AbstractforThe place of pegvisomant in the management of acromegaly | References | PDF (206.1 KB)

53 Views
12 CrossRef citations
0Altmetric

Trimegestone: expanding therapeutic choices for the treatment of the menopause

Farook Al-Azzawi & May Wahab

Pages: 1737-1744

Published online: 24 Feb 2005

AbstractforTrimegestone: expanding therapeutic choices for the treatment of the menopause | References | PDF (121 KB)

43 Views
4 CrossRef citations
0Altmetric

Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts

Pages: 1745-1753

Published online: 24 Feb 2005

AbstractforOral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts | References | PDF (192.2 KB)

159 Views
45 CrossRef citations
0Altmetric

Statins in the 21st century: end of the simple story?

Sheila A Doggrell

Pages: 1755-1766

Published online: 24 Feb 2005

AbstractforStatins in the 21st century: end of the simple story? | References | PDF (183.3 KB)

59 Views
19 CrossRef citations
0Altmetric

A small-molecule antagonist of virion assembly

Pages: 1767-1770

Published online: 24 Feb 2005

First Page PreviewforA small-molecule antagonist of virion assembly | References | PDF (62.8 KB)

22 Views
3 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

Luca Iorio et al.

Report | Published online: 16 Jun 2024

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 15 Jun 2024

Free Access

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy

Ava Aghakhani et al.

Review Article | Published online: 30 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.10, Iss.9, 2001)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?

Information for

Authors
R&D professionals
Editors
Librarians
Societies

Open access

Overview
Open journals
Open Select
Dove Medical Press
F1000Research

Opportunities

Reprints and e-prints
Advertising solutions
Accelerated publication
Corporate access solutions

Help and information

Help and contact
Newsroom
All journals
Books

Keep up to date

Register to receive personalised research and resources by email

Taylor and Francis Group Facebook page

Taylor and Francis Group X Twitter page

Taylor and Francis Group Linkedin page

Taylor and Francis Group Youtube page

Taylor and Francis Group Weibo page

Copyright © 2024Informa UK Limited Privacy policy Cookies Terms & conditions Accessibility

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG